Important FDA Disclosure About Compounded GLP-1 Medications Compounded GLP-1 medications are not FDA-approved
Retatrutide is being studied for: Type 2 diabetes MASH(Metabolic Dysfunction-Associated Steatohepatitis), a liver condition caused by fat buildup Heart disease risk reduction Knee osteoarthritis in people with higher body weight More research is needed before doctors know whether retatrutide is safe and effective for these conditions
Kumar says that more research is needed to understand what drives these effects, and GLP-1s are not currently FDA-approved to treat addiction disorders
Bariatric surgery + GLP-1 If youve had a malabsorptive bariatric surgery (like a Roux-en-Y gastric bypass or biliopancreatic diversion), birth control pill absorption is already reduced by the surgery
This route offers a high bioavailability of 89%, with peak concentrations reached within 1-3 days and steady-state occurring after 4-5 weeks [9, 13]
Phase 3 trials in obesity, obesity with knee osteoarthritis, and type 2 diabetes have reported results